Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib

BACKGROUND: Low skeletal muscle mass is significantly associated with severe adverse events (AEs) from chemotherapy, and low tolerability leads to decreased survival. We aimed to investigate whether body skeletal muscle mass is correlated with tolerability and prognosis in patients with hepatocellul...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Cancer
Autors principals: Uojima, Haruki, Chuma, Makoto, Tanaka, Yoshiaki, Hidaka, Hisashi, Nakazawa, Takahide, Iwabuchi, Shogo, Kobayashi, Satoshi, Hattori, Nobuhiro, Ogushi, Katsuaki, Morimoto, Manabu, Kagawa, Tatehiro, Tanaka, Katsuaki, Kako, Makoto, Koizumi, Wasaburo
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2020
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206580/
https://ncbi.nlm.nih.gov/pubmed/32399433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars